过去一年中添加的文章，按日期排序
Successful Application of Tocilizumab in a Patient With Neoadjuvant Immunochemotherapy‐Induced Cytokine Release Syndrome
S Minami, Y Kawashima, Y Munakata… - Cancer …, 2024 - Wiley Online Library
11 天前 - … the number of patients with lung cancer receiving immune checkpoint inhibitors (ICIs).
Therefore, oncologists should manage a variety of immune-related adverse events (irAEs)…
Therefore, oncologists should manage a variety of immune-related adverse events (irAEs)…
A case of biopsy‐proven acute interstitial nephritis following atezolizumab‐bevacizumab treatment of advanced unresectable hepatocellular carcinoma
R Patel, O Elghawy, A Gibbs, S Gupta… - Cancer Reports, 2024 - Wiley Online Library
11 天前 - … of immune checkpoint inhibitors (ICIs… treatment for unresectable hepatocellular
carcinoma (HCC). Exposure to a novel and diverse spectrum of immune-related adverse events (…
carcinoma (HCC). Exposure to a novel and diverse spectrum of immune-related adverse events (…
Immune checkpoint blockade effect on immunologic and virologic profile of five cancer patients living with human immunodeficiency virus (HIV) infection
A Yazji, EN Brown, R De La Torre… - Journal of Oncology …, 2024 - journals.sagepub.com
13 天前 - … immune checkpoint inhibitors may enhance HIV disease control. Further research is
needed for this … absence of documented immune-related adverse events of any grade in all …
needed for this … absence of documented immune-related adverse events of any grade in all …
[HTML][HTML] Immune Checkpoint Inhibitor-Related Myocarditis: A Case Series and Literature Review
C Chu, HY Liang, MY Lien, HP Wu - Acta Cardiologica Sinica, 2024 - ncbi.nlm.nih.gov
13 天前 - … However, the immune system might also misrecognize … immune response is an
immune-related adverse event (irAE). … the treatment experience of three patients diagnosed with …
immune-related adverse event (irAE). … the treatment experience of three patients diagnosed with …
Misdiagnosis of severe and atypical oxaliplatin‑related hypersensitivity reaction following chemotherapy combined with PD‑1 inhibitor: A case report and literature …
M Sun, G Xu, L Cai, S He - Oncology Letters, 2024 - spandidos-publications.com
13 天前 - … courses were suspected to be immune-related adverse events (irAEs) induced by
tislelizumab, causing multiple organ damage. The adverse events of the third course involved …
tislelizumab, causing multiple organ damage. The adverse events of the third course involved …
[HTML][HTML] Safety of immune checkpoint inhibitor rechallenge after severe immune-related adverse events: a retrospective analysis
C Eldani, M Kostine, M Faure, E Lazaro… - Frontiers in …, 2024 - ncbi.nlm.nih.gov
13 天前 - … Immune checkpoint inhibitors (ICIs) present clinicians with the challenge of managing
immune-related adverse events … mild to severe due to immune system activation 1 . While …
immune-related adverse events … mild to severe due to immune system activation 1 . While …
[PDF][PDF] Secondary Adrenal Insufficiency as an Immune-Related Adverse Event of Pembrolizumab Therapy
L Escaño, P Desai - Cureus, 2024 - cureus.com
14 天前 - … in patients treated with immune checkpoint inhibitors, as early recognition and
appropriate intervention are paramount to preventing serious complications in these patients. …
appropriate intervention are paramount to preventing serious complications in these patients. …
… of Immune Checkpoint Inhibitors Occurs in Esophageal Cancer Patients With a Low Neutrophil-to-Lymphocyte Ratio and Good Performance Status Prior to Treatment
Y Hirasawa, Y Kubota, E Mura, R Suzuki… - Anticancer …, 2024 - ar.iiarjournals.org
14 天前 - … patients achieve long-term survival, and some patients develop serious immune-related
adverse events (… Immune-related adverse events in EC patients treated with nivolumab …
adverse events (… Immune-related adverse events in EC patients treated with nivolumab …
Anti-tumor immunity and vitiligo: from immune-related adverse reactions to protection from cancer
R Mazzetto, A Sernicola, P Miceli, J Tartaglia… - …, 2024 - Taylor & Francis
14 天前 - … of anti-tumor immunity related to vitiligo beyond that of leukoderma in patients
treated with immune checkpoint inhibitors to that of a broader immunological reaction against …
treated with immune checkpoint inhibitors to that of a broader immunological reaction against …
[HTML][HTML] Acknowledging and addressing real-world challenges to treating immune-related adverse events
MS von Itzstein, DE Gerber, BL Bermas… - … for Immunotherapy of …, 2024 - ncbi.nlm.nih.gov
14 天前 - … with the toxicities of the revolutionary immune checkpoint inhibitor (ICI) therapies.
While … nascent stage of understanding and management of their adverse events. Imagine an …
While … nascent stage of understanding and management of their adverse events. Imagine an …